Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2347${count})

  • Research Grant, 2018
    Inducing Aging in Brain Cells to Better Understand Parkinson's Disease

    Study Rationale:
    Age is the biggest risk factor for Parkinson's disease (PD), with disease incidence rising steeply among persons 60 or older. The reason for this remains unknown. Research suggests...

  • Therapeutic Pipeline Program, 2018
    Developing a Blocker of Alpha-synuclein Production for the Treatment of Parkinson's Disease

    Study Rationale:
    Alpha-synuclein is a sticky protein that clumps in the brains of people with Parkinson's disease (PD). Duplication or triplication of SNCA, a gene responsible for the production of...

  • LEAPS, 2018
    Studying LRRK2 Mutations as a Possible Cause of Waste Buildup in Nerve Cells

    Study Rationale:
    Health and longevity of brain cells depends on the efficiency of their waste removal process, known as autophagy or self-eating. Cells use autophagy to get rid of unwanted protein...

  • Research Grant, 2018
    The Role of LRRK2 Activity in Inherited Parkinson's Disease

    Promising Outcomes of Original Grant:
    Mutations (changes) in the LRRK2 gene are a leading genetic cause of Parkinson's disease (PD). Previously, we sought to evaluate the connection between a common PD...

  • Improved Biomarkers and Clinical Outcome Measures, 2018
    A Tool for Evaluating Facial Expression for Early Diagnosis of Parkinson's Disease

    Study Rationale:
    The hypomimia -- decreased facial expression with reduced blinking -- is a major motor sign of Parkinson's disease (PD). This clinical sign indicates movement dysfunction early in the...

  • Research Grant, 2018
    New Imaging Agents for Parkinson's Disease and Related Disorders

    Study Rationale:
    Imaging is a powerful tool that can be used to visualize the structure and function of the brain in living subjects. In this study, we aim to develop a new brain imaging chemical...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.